Cell–cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer
Hayato Ishii, Kyoka Nishiyama, Ayaka Nakahara, Shoma Tamori, Shigeo Ohno, Kazunori Sasaki, Kazunori Akimoto · 2026
Read Cell–cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer by Hayato Ishii, Kyoka Nishiyama, Ayaka Nakahara, Shoma Tamori, Shigeo Ohno, Kazunori Sasaki, Kazunori Akimoto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352254.txt.
Description
Hayato Ishii and six colleagues mine breast cancer data for prognostic signals in this 2026 study. Their focus is the genes that build junctions between cells. Those junctions hold epithelial tissue together, and their failure has long been tied to cancer spread. The team analysed one hundred seventy-nine junction genes across breast cancer subtypes. Two large datasets supplied the discovery material. An independent Scandinavian cohort provided validation.
A combined junction signature predicted survival within subtypes. High scores meant poorer outcomes nearly everywhere. The effect bit hardest in Luminal B and basal-like tumours, the aggressive kinds. High scores also forecast recurrence inside the first five years. Such tumours switched on matrix and scaffolding pathways, as if loosening their moorings. Single-cell data showed which cells carry the signature genes. A junction-based score could help oncologists spot, early, the patients whose cancers are likeliest to return.
Catalog record
| CREATOR | Hayato Ishii, Kyoka Nishiyama, Ayaka Nakahara, Shoma Tamori, Shigeo Ohno, Kazunori Sasaki, Kazunori Akimoto |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79332 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |